Author | Patrick Gleason, PharmD, FCCP, BCPS

Articles

5 things to know about cholesterol-lowering PCSK9 inhibitors

June 12, 2015

Article

This summer, the first two drugs in the new class of cholesterol-lowering medications, known as PCSK9 inhibitors, are expected to be approved by the FDA. If approved, PCSK9 inhibitors will change how chronic conditions are treated.